Bioject Medical Technologies In
(BJCT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2001 | 12-2000 | 03-2000 | 12-1999 | 03-1999 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -6,025 | 0 | -3,082 | 0 | -7,076 |
| Depreciation Amortization | 623 | 470 | 731 | 540 | 708 |
| Accounts receivable | -313 | 0 | 178 | 0 | -151 |
| Accounts payable and accrued liabilities | 119 | 0 | 4 | 0 | -307 |
| Other Working Capital | -269 | 170 | 369 | 600 | -111 |
| Other Operating Activity | 2,048 | 0 | 655 | 0 | 3,812 |
| Operating Cash Flow | $-3,817 | $640 | $-1,145 | $1,140 | $-3,126 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -8,803 | 0 | N/A | 0 | N/A |
| PPE Investments | -289 | -160 | -99 | -80 | -358 |
| Net Acquisitions | N/A | 0 | N/A | -330 | N/A |
| Purchase Of Investment | N/A | 0 | -332 | 0 | N/A |
| Other Investing Activity | -108 | -12,360 | -67 | 0 | -111 |
| Investing Cash Flow | $-9,200 | $-12,520 | $-497 | $-410 | $-469 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -5 | 0 | N/A | 0 | N/A |
| Common Stock Issued | 12,393 | 0 | 4,850 | 0 | 2,969 |
| Other Financing Activity | 0 | 11,150 | 2,400 | 2,500 | 0 |
| Financing Cash Flow | $12,388 | $11,150 | $7,250 | $2,500 | $2,969 |
| Beginning Cash Position | 6,884 | 0 | 1,274 | 0 | 1,901 |
| End Cash Position | 6,255 | 0 | 6,884 | 0 | 1,274 |
| Net Cash Flow | $-629 | $-730 | $5,609 | $3,230 | $-627 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,817 | 640 | -1,145 | 1,140 | -3,126 |
| Capital Expenditure | -299 | 0 | -99 | 0 | -358 |
| Free Cash Flow | -4,115 | 640 | -1,243 | 1,140 | -3,484 |